Healthcare Realty Trust Earnings Call Transcripts
Fiscal Year 2026
-
Record Q1 leasing and NOI growth led to raised FFO and Same-Store guidance, with disciplined capital allocation and robust operational momentum. Occupancy and retention rates improved, redevelopment and JV activity accelerated, and balance sheet strength was maintained.
Fiscal Year 2025
-
2025 results exceeded expectations with strong leasing, improved margins, and reduced leverage. 2026 guidance projects stable FFO, continued NOI growth, and disciplined capital allocation, supported by robust demand and a strengthened balance sheet.
-
Strong Q3 results featured 5% FFO growth, robust leasing, and accelerated asset sales, driving leverage below 6x and prompting raised guidance. Portfolio repositioning and operational improvements are expected to sustain NOI and margin gains into 2026.
-
Q2 delivered strong FFO and NOI growth, driven by higher occupancy, cost savings, and robust leasing. The strategic plan focuses on operational excellence, portfolio optimization, and capital reinvestment, with a $1B disposition target and a 23% dividend cut to fund growth.
-
Q1 results met expectations with normalized FFO per share at $0.39 and stable NOI growth. Strategic priorities include leasing, portfolio optimization, and deleveraging, with a focus on efficiency and margin improvement. Dividend maintained, with future policy tied to strategic plan execution.
Fiscal Year 2024
-
Normalized FFO per share grew 2.5% year-over-year, with record leasing and strong tenant retention. 2025 priorities include operational growth, portfolio refinement, and significant debt reduction, with dividend coverage targeted by late 2025 or early 2026.
-
Q3 2024 delivered strong leasing, NOI growth, and a return to year-over-year FFO per share growth. Asset sales and share repurchases enhanced capital flexibility, while Steward bankruptcy impacts are being actively managed with most NOI exposure secured or in process.
-
Q2 2024 saw strong FFO and NOI growth, robust leasing, and improved occupancy, with over $1 billion in JV and asset sale proceeds expected. Guidance was raised, leverage is set to decline, and dividend coverage is on track for 2025, supported by favorable market trends.